To confirm the presence of HCs in tissue sections, we analyzed publicly available datasets of normal colon and tumor (stage 2A colon adenocarcinoma) sections that were analyzed using a recently developed Xenium high-resolution in situ targeted panel of 425 genes including EPCAM, KRT8, CD14, and C163. This evidence concerns the gene EPCAM and colon adenocarcinoma.